Clostridioides difficile is one of the most important causes of healthcare-associated diarrhea.
The high incidence and recurrence rates of C. difficile infection, as well as its associated …

ABSTRACT Introduction Updating data on Clostridioides difficile antibiotic resistance is
important for treatment improvement of C. difficile infections (CDIs). Areas covered Results …

The coronavirus disease 2019 (COVID-19)-pandemic-related overload of health systems
has compromised the application of antimicrobial stewardship (AS) models and infection …

Clostridioides difficile infection (CDI) affects approximately 500,000 patients annually in the
United States, of these around 30,000 will die. CDI carries significant burdens including …

Clostridioides difficile is the most common cause of antibiotic-associated diarrhoea globally.
Its spores have been implicated in the prevalence of C. difficile infection due to their …

Clostridioides difficile infections (CDIs) have decreased in the past years, but since 2021,
some hospitals have reported an increase in CDI rates. CDI remains a global concern and …

(1) Background: Clostridioides difficile (C. difficile) and SARS-CoV-2 coronavirus represent
significant health threats. Our study focused on the impact of concurrent infections on patient …

Clostridioides difficile infection (CDI) is the main source of healthcare and antibiotic-
associated diarrhea in hospital context and long-term care units, showing significant …

Objectives Clostridioides difficile infection (CDI) causes the greatest number of healthcare-
associated infectious diarrhoea. CDIs are transmitted by direct and indirect patient-to-patient …

Clostridioides difficile causes the highest number of nosocomial infections. Currently,
treatment options for C. difficile infection (CDI) are very limited, resulting in poor treatment …